ASCO 2021
ASCO 2021
Advertisement
DocWire News EditorsASCO 2021 | August 3, 2022
Does a restrictive opioid prescription protocol impact the patient experience?
Read More
DocWire News EditorsASCO 2021 | August 25, 2022
The risk of disease recurrence is high among patients with muscle-invasive urothelial carcinoma following radical ...
DocWire News EditorsASCO 2021 | August 25, 2022
In the study, a total of 117 men underwent 18F-DCFPyL-PET/CT.
DocWire News EditorsASCO 2021 | August 30, 2022
Evaluating the effects of low household income on diagnosis, goals of care, and treatment choice in prostate cancer ...
DocWire News EditorsASCO 2021 | April 25, 2023
Evaluating efficacy of a cancer peptide vaccine plus pembrolizumab for locally advanced or metastatic urothelial ...
DocWire News EditorsASCO 2021 | August 30, 2022
Assessing germline variants in patients who did and did not meet the NCCN 2019 PCa germline genetic testing criteria.
DocWire News EditorsASCO 2021 | August 30, 2022
Staging with PSMA-PET/CT and response classification by Response Evaluation Criteria had prognostic value in prostate ...
DocWire News EditorsASCO 2021 | August 30, 2022
Researchers evaluated patients with localized MIBC in clinical stages T2-4a who had no contraindications to ...
DocWire News EditorsASCO 2021 | August 30, 2022
Racial disparities have been identified in prostate MRI and may affect outcomes for Black men with prostate cancer.
DocWire News EditorsASCO 2021 | August 30, 2022
A study evaluated trends in outpatient prostate cancer throughout the COVID-19 pandemic using a community-based ...
DocWire News EditorsASCO 2021 | August 30, 2022
Is PSMA expression is a reliable predictor of response to Lu-177 PSMA in patients with castration-resistant prostate ...
Rebecca AraujoASCO 2021 | September 22, 2023
Data on durable efficacy of two investigational chemotherapy-free treatments for non-small cell lung cancer (NSCLC) or ...
Rebecca AraujoASCO 2021 | April 6, 2023
Teclistamab and talquetamab, two investigational bispecific antibodies, showed promising responses for the treatment of ...
Advertisement
Advertisement
Advertisement
Latest News

May 14, 2024